我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
67
4 进行中
药物批准
10
批准总数
监管机构
2
监管机构数
成立时间
N/A
进行中（未招募）
4
6.0%
已完成
43
64.2%
招募中
1
1.5%
终止
3.0%
Unknown
16
23.9%
撤回
NMPA
National Medical Products Administration
3
PHILIPPINES
Philippines FDA
7
• South Korea's government has unveiled an ambitious five-point strategy to revolutionize its bio-health industry, focusing on innovation in medical services, export growth, and AI-driven R&D advancement. • The country's life sciences sector is experiencing rapid growth through substantial public-private investments, supported by advanced infrastructure and a highly skilled STEM workforce. • Major players like Samsung Biologics, LG Chem, and Celltrion are driving industry growth, while government initiatives provide robust support for biotech startups and research development.
